title: Parenchymal signal intensity in 3-T body MRI of dogs with hematopoietic neoplasia.
abstract: We performed a preliminary study involving 10 dogs to assess the applicability of body MRI for staging of canine diffuse hematopoietic neoplasia. T1-weighted (before and after intravenous gadolinium), T2-weighted, in-phase, out-of-phase, and short tau inversion recovery pulse sequences were used. By using digital region of interest (ROI) and visual comparison techniques, relative parenchymal organ (medial iliac lymph nodes, liver, spleen, kidney cortex, and kidney medulla) signal intensity was quantified as less than, equal to, or greater than that of skeletal muscle in 2 clinically normal young adult dogs and 10 dogs affected with either B-cell lymphoma (n = 7) or myelodysplastic syndrome (n = 3). Falciform fat and urinary bladder were evaluated to provide additional perspective regarding signal intensity from the pulse sequences. Dogs with nonfocal disease could be distinguished from normal dogs according to both the visual and ROI signal-intensity relationships. In normal dogs, liver signal intensity on the T2-weighted sequence was greater than that of skeletal muscle by using either the visual or ROI approach. However in affected dogs, T2-weighted liver signal intensity was less than that of skeletal muscle by using either the ROI approach (10 of 10 dogs) or the visual approach (9 of 10 dogs). These findings suggest that the comparison of relative signal intensity among organs may have merit as a research model for infiltrative parenchymal disease (ROI approach) or metabolic effects of disease; this comparison may have practical clinical applicability (visual comparison approach) as well.
authors.affiliation: Department of Veterinary Clinical Sciences, University of Minnesota, St Paul, Minnesota, USA. feene001@umn.edu
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Feeney
authors.forename: Leslie C
authors.initials: LC
authors.lastname: Sharkey
authors.forename: Susan M
authors.initials: SM
authors.lastname: Steward
authors.forename: Katherine L
authors.initials: KL
authors.lastname: Bahr
authors.forename: Michael S
authors.initials: MS
authors.lastname: Henson
authors.forename: Daisuke
authors.initials: D
authors.lastname: Ito
authors.forename: Timothy D
authors.initials: TD
authors.lastname: O'Brien
authors.forename: Carl R
authors.initials: CR
authors.lastname: Jessen
authors.forename: Brian D
authors.initials: BD
authors.lastname: Husbands
authors.forename: Antonella
authors.initials: A
authors.lastname: Borgatti
authors.forename: Jaime F
authors.initials: JF
authors.lastname: Modiano
mesh_terms: D000818:Animals; D004283:Dog Diseases / Q000175:diagnosis / Q000473:pathology*; D004285:Dogs; D019337:Hematologic Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000662:veterinary*; D016393:Lymphoma, B-Cell / Q000175:diagnosis / Q000473:pathology / Q000662:veterinary; D008279:Magnetic Resonance Imaging / Q000379:methods / Q000662:veterinary*; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000473:pathology / Q000662:veterinary; D009367:Neoplasm Staging / Q000379:methods / Q000662:veterinary*; D010865:Pilot Projects